DENTSPLY SIRONA Inc. (XRAY) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-01-14

Key Insights

DENTSPLY SIRONA has entered into new non-exclusive distribution agreements with Patterson for the distribution of dental equipment in the United States, which could expand the company's reach and distribution channels.
The filing does not provide any financial details or performance metrics, so the financial impact of these new distribution agreements is unclear.
The company's stock price and financial performance should be monitored for any changes that may result from these new distribution agreements.

Want the newest filings?

This analysis covers the filing from 2026-01-14. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-01-13

DENTSPLY SIRONA has expanded its board of directors from 10 to 11 members, appointing Donald J. Zurbay as a new independent director effective immediately.
Zurbay will serve on the Audit and Finance Committee, adding relevant financial expertise to the board.
The company's press release indicates this is a routine board change, as Zurbay does not have any direct or indirect material interests in the company.

Filed: 2025-12-31

DENTSPLY SIRONA has amended its revolving credit facility and various note purchase agreements to establish new financial covenants, including a total leverage ratio and a senior leverage ratio, as well as a restriction on restricted payments.
The amendments allow the company to maintain compliance with its debt covenants, as the previous covenants were replaced with less stringent ones, providing more flexibility.
The company has also agreed to limits on the addback of charges and expenses related to its efficiency initiatives, which could impact its future EBITDA calculations and financial performance.

Other reports for DENTSPLY SIRONA Inc.

Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.